Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Humacyte Inc (NQ: HUMA )

3.525 -0.175 (-4.72%)
Streaming Delayed Price Updated: 3:49 PM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 546,807
Open 3.850
Bid (Size) 3.510 (7)
Ask (Size) 3.530 (7)
Prev. Close 3.700
Today's Range 3.500 - 3.960
52wk Range 1.960 - 6.380
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Scheduled For May 12, 2023
Companies Reporting Before The Bell • Honda Motor Co (NYSE:HMC) is expected to report earnings for its fourth quarter. 
Via Benzinga
Recap: Humacyte Q1 Earnings
 
Via Benzinga

Performance

YTD
+67.07%
+67.07%
1 Month
+5.23%
+5.23%
3 Month
+17.51%
+17.51%
6 Month
+14.08%
+14.08%
1 Year
-35.08%
-35.08%

More News

Read More
Earnings Outlook For Humacyte
Via Benzinga
Earnings Scheduled For March 24, 2023
Via Benzinga
Humacyte Announces Fourth Quarter and Year End 2022 Financial Results and Business Update
From Humacyte, Inc
Via GlobeNewswire
Earnings Preview For Humacyte
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023
From Humacyte, Inc
Via GlobeNewswire
Humacyte to Present at Upcoming Investor Conferences in March
From Humacyte, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Humacyte Publication in the Journal of Vascular Surgery – Vascular Science Reports the Human Acellular Vessel™ (HAV™) Remains Durable at Six Years in Patients with Peripheral Artery Disease
From Humacyte, Inc
Via GlobeNewswire
5 Value Stocks In The Healthcare Sector
Via Benzinga
Humacyte's Return on Invested Capital Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Humacyte Hosting Key Opinion Leader Webinar on Vascular Trauma: Ukrainian Surgeons Discuss Use of Human Acellular Vessels™ (HAV™) in Wartime
From Humacyte, Inc
Via GlobeNewswire
Sidoti's December Small-Cap Virtual Conference
Via ACCESSWIRE
Humacyte Human Acellular Vessel™ (HAV™) Ukraine Humanitarian Results to be Presented at Multiple Vascular Conferences in December 2022
From Humacyte, Inc
Via GlobeNewswire
Humacyte to Present at the 34th Annual Piper Sandler Healthcare Conference
From Humacyte, Inc
Via GlobeNewswire
Imago BioSciences, GrafTech International And Some Other Big Stocks Moving Higher On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Humacyte Third Quarter 2022 Financial Results and Business Update
From Humacyte, Inc
Via GlobeNewswire
Humacyte Presents Six-Month Human Acellular Vessel™ (HAV™) Coronary Artery Bypass Graft (CABG) Data at the American Heart Association Scientific Sessions 2022 Meeting
From Humacyte, Inc
Via GlobeNewswire
Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 10, 2022
From Humacyte, Inc
Via GlobeNewswire
Livent, Amgen And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.